IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells.


Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
2022
Historique:
received: 06 04 2022
accepted: 07 05 2022
entrez: 9 6 2022
pubmed: 10 6 2022
medline: 10 6 2022
Statut: epublish

Résumé

Interleukin-33 (IL-33) is an IL-1 family cytokine known to promote T-helper (Th) type 2 immune responses that are often deregulated in gastric cancer (GC). IL-33 is overexpressed in human gastric tumours suggesting a role in driving GC progression although a causal link has not been proven. Here, we investigated the impact of IL-33 genetic deficiency in the well-characterized

Identifiants

pubmed: 35677533
doi: 10.18632/oncotarget.28238
pii: 28238
pmc: PMC9159270
doi:

Substances chimiques

Cytokines 0
IL33 protein, human 0
Il33 protein, mouse 0
Interleukin-1 Receptor-Like 1 Protein 0
Interleukin-33 0
Cytokine Receptor gp130 133483-10-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

785-799

Informations de copyright

Copyright: © 2022 Tran et al.

Déclaration de conflit d'intérêts

CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.

Références

Dig Dis Sci. 2011 Dec;56(12):3596-601
pubmed: 21643739
Gut. 2018 May;67(5):805-817
pubmed: 28196875
J Immunol. 2009 Nov 15;183(10):6469-77
pubmed: 19841166
Immunity. 2015 Mar 17;42(3):566-79
pubmed: 25786179
PLoS One. 2008 Oct 06;3(10):e3331
pubmed: 18836528
Genomics. 2000 Aug 1;67(3):284-90
pubmed: 10936050
Nat Commun. 2019 Jun 21;10(1):2735
pubmed: 31227713
Gastroenterology. 2004 Jan;126(1):196-207
pubmed: 14699500
BMC Immunol. 2010 Oct 19;11:52
pubmed: 20958987
N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
Oncoimmunology. 2015 Jun 26;5(1):e1062966
pubmed: 26942077
Nature. 2010 Apr 29;464(7293):1367-70
pubmed: 20200518
Int Immunol. 2008 Aug;20(8):1019-30
pubmed: 18550585
Science. 1996 Oct 11;274(5285):259-62
pubmed: 8824193
Gastroenterology. 2010 Dec;139(6):2005-17
pubmed: 20801119
Gastroenterology. 2009 Mar;136(3):967-77
pubmed: 19121317
Cancer Metastasis Rev. 2011 Mar;30(1):45-60
pubmed: 21287360
J Int Med Res. 2012;40(5):1654-61
pubmed: 23206447
Mol Oncol. 2016 Jan;10(1):113-25
pubmed: 26433471
J Biol Chem. 2007 Sep 7;282(36):26369-80
pubmed: 17623648
Nat Med. 2002 Oct;8(10):1089-97
pubmed: 12219085
Am J Physiol Gastrointest Liver Physiol. 2019 Feb 1;316(2):G251-G262
pubmed: 30520693
J Immunol. 2001 Feb 1;166(3):2090-9
pubmed: 11160260
Biochem Biophys Res Commun. 2001 Aug 3;285(5):1377-83
pubmed: 11478810
J Clin Invest. 2016 Apr 1;126(4):1383-400
pubmed: 26974160
Nat Immunol. 2008 Nov;9(11):1215-23
pubmed: 18936782
Oncogene. 2015 May 28;34(22):2856-66
pubmed: 25088199
J Immunol. 2008 Nov 1;181(9):5981-9
pubmed: 18941187
J Cell Biol. 1996 Oct;135(1):279-90
pubmed: 8858180
J Immunol. 2009 Oct 15;183(8):5094-103
pubmed: 19801525
EMBO J. 1994 Mar 1;13(5):1176-88
pubmed: 8131748
Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G175-G188
pubmed: 32538140
J Clin Invest. 2008 May;118(5):1727-38
pubmed: 18431520
Cell Mol Gastroenterol Hepatol. 2015 Jan 03;1(2):203-221.e3
pubmed: 28210674
Cancer Lett. 2015 Aug 10;364(2):173-80
pubmed: 25986744
Front Immunol. 2020 Jul 03;11:1389
pubmed: 32719677
FEBS Lett. 1989 Dec 4;258(2):301-4
pubmed: 2532153
Immune Netw. 2010 Feb;10(1):15-25
pubmed: 20228932
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):308-13
pubmed: 21173249
J Immunol Methods. 2015 Dec;427:126-9
pubmed: 26478184
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):282-7
pubmed: 17185418
Biochem Biophys Res Commun. 2016 Oct 21;479(3):461-468
pubmed: 27644880
J Immunol. 1998 Nov 1;161(9):4866-74
pubmed: 9794420
Nat Commun. 2016 Nov 24;7:13589
pubmed: 27882929
Cancer Cell. 2005 Mar;7(3):211-7
pubmed: 15766659
J Immunol Res. 2018 Feb 5;2018:2584243
pubmed: 29651440
J Allergy Clin Immunol. 2008 Jun;121(6):1484-90
pubmed: 18539196
J Immunol. 2015 Jan 1;194(1):438-45
pubmed: 25429071
J Immunol Methods. 2012 Aug 31;382(1-2):160-6
pubmed: 22683543
Gastroenterology. 2016 May;150(5):1113-1124.e5
pubmed: 26836587
Pathol Oncol Res. 2017 Jul;23(3):615-619
pubmed: 28000059
J Pathol. 2007 Oct;213(2):140-51
pubmed: 17724739
Front Immunol. 2014 Apr 07;5:141
pubmed: 24778632
Immunity. 2005 Nov;23(5):479-90
pubmed: 16286016
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6930-5
pubmed: 9618516
Gastroenterology. 2006 Oct;131(4):1073-85
pubmed: 17030178
Gastroenterology. 1999 Sep;117(3):605-18
pubmed: 10464136

Auteurs

Chau P Tran (CP)

Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Michelle Scurr (M)

Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Louise O'Connor (L)

Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Jon N Buzzelli (JN)

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

Garrett Z Ng (GZ)

Mucosal Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Sharleen Chung Nien Chin (SCN)

Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Lincon A Stamp (LA)

Department of Anatomy and Physiology, The University of Melbourne, Victoria, Australia.

Toshinari Minamoto (T)

Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.

Andrew S Giraud (AS)

Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

Louise M Judd (LM)

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

Philip Sutton (P)

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Mucosal Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Co-senior authors.

Trevelyan R Menheniott (TR)

Tumour Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Mucosal Immunology Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Co-senior authors.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH